A tailored course, built for your situation
Mastering ISO 22301 for Global Biomanufacturing COOs
Build unbroken operational resilience across complex biopharma production networks
$199 one-time
24-hour access provisioning
30-day money-back guarantee
Hand-built implementation playbook
12 modules. 12 chapters per module. 144 chapters total.
12 modules, each with 12 chapters (144 chapters total), text-based, plus downloadable templates and a hand-built implementation playbook delivered alongside course access.
Even robust continuity plans fail when they’re not tied to real production timelines and regulator-expected recovery SLAs
The situation this course is for
Teams often treat ISO 22301 as a documentation exercise, until an audit reveals gaps in actual recovery capability, triggering delays, cost overruns, and lost confidence from partners and regulators.
Who this is for
A senior operations leader in biopharma manufacturing, accountable for uptime, compliance, and end-to-end process integrity across global sites
Who this is not for
Junior compliance staff, consultants without biomanufacturing exposure, or practitioners focused solely on IT disaster recovery
What you walk away with
- Deliver ISO 22301-aligned recovery playbooks that pass third-party review without revisions
- Lead funded resilience programs across multi-site bioprocessing environments
- Align continuity benchmarks with FDA and EMA uptime expectations
- Turn audit findings into strategic improvement cycles without operational disruption
- Secure leadership buy-in for proactive continuity investments ahead of regulatory cycles
The 12 modules (with all 144 chapters)
Module 1. Foundations of ISO 22301 in Biopharmaceutical Manufacturing
Establish the core principles of business continuity management specific to cGMP environments, including regulatory alignment with MHRA, FDA, and EMA expectations.
12 chapters in this module
- Defining criticality in biomanufacturing continuity planning
- Mapping ISO 22301 to cGMP and current Good Manufacturing Practice standards
- Identifying single points of failure in bulk production workflows
- Integrating continuity with existing quality management systems
- Role of COO in continuity governance and oversight
- Benchmarking recovery time objectives in filling and purification
- Documenting critical process dependencies across sites
- Aligning business continuity with regulatory inspection readiness
- Maintaining continuity during facility expansion cycles
- Integrating vendor recovery SLAs into continuity plans
- Managing personnel continuity during leadership transitions
- Using ISO 22301 to strengthen partner confidence in supply reliability
Module 2. Risk Assessment Specific to Bioprocess Environments
Adapt ISO 22301 risk methodology to high-value, low-volume biologics production, including fermentation, purification, and fill-finish operations.
12 chapters in this module
- Identifying mission-critical equipment with no alternates
- Assessing vulnerability of single-use systems supply chain
- Mapping raw material dependencies across global suppliers
- Evaluating impact of power loss on bioreactor runs
- Quantifying financial exposure from batch interruption
- Defining acceptable downtime for cold chain logistics
- Assessing cyber-physical risks in automated process control
- Evaluating staffing continuity during public health events
- Integrating pandemic response into business continuity planning
- Assessing facility-level risks in multi-tenant campuses
- Prioritizing risks using regulatory scrutiny weighting
- Building risk heat maps aligned with audit expectations
Module 3. Developing Biopharma-Specific Business Impact Analyses
Conduct precise impact analyses that reflect the financial, regulatory, and reputational stakes of production downtime in biologics.
12 chapters in this module
- Calculating revenue impact per hour of fill-finish delay
- Estimating cost of batch reprocessing after failure
- Assessing contract penalty exposure from missed deliveries
- Quantifying patient impact of delayed oncology biologics
- Measuring reputational damage from partner escalations
- Aligning BIA thresholds with FDA enforcement discretion
- Using batch lifecycle data to inform recovery priorities
- Mapping BIA findings to quality event reporting timelines
- Integrating supply chain visibility into impact modeling
- Factoring in regulatory review clock impact from delays
- Benchmarking BIA rigor across peer biomanufacturers
- Presenting BIA outcomes to executive leadership teams
Module 4. Designing ISO 22301-Compliant Recovery Strategies
Engineer recovery strategies that ensure continuity of complex bioprocesses while meeting ISO 22301 requirements and regulatory expectations.
12 chapters in this module
- Dual-site production readiness for high-value molecules
- Cold chain redundancy planning for global distribution
- Recovery workflows for single-use bioreactor systems
- Cross-training plans for critical process operators
- Backup facility qualification for emergency transfer
- Validated alternate methods for purification steps
- Recovery of electronic batch records after system failure
- Rapid revalidation pathways for resumed operations
- Spare parts inventory strategies for critical equipment
- Vendor recovery commitments in execute-ready formats
- Regulatory notification planning for production shifts
- Recovery validation against pre-defined success criteria
Module 5. Continuity Plan Development for Multi-Site Networks
Build integrated continuity plans across global manufacturing footprints with shared standards and mutual recognition.
12 chapters in this module
- Standardizing continuity protocols across regions
- Aligning recovery SLAs with local regulatory bodies
- Cross-border data flow in continuity monitoring
- Language and documentation consistency in multilingual teams
- Centralized vs decentralized plan ownership models
- Incident escalation paths across time zones
- Harmonizing training schedules across sites
- Validating plan interoperability during joint exercises
- Managing differing risk appetites across locations
- Integrating local utility dependencies into global plans
- Ensuring GxP compliance in emergency recovery modes
- Auditing plan effectiveness across jurisdictions
Module 6. Exercising and Maintaining Biopharma Continuity Plans
Run effective continuity exercises that validate readiness without disrupting ongoing production or regulatory compliance.
12 chapters in this module
- Designing tabletop exercises for regulatory inspections
- Running simulated batch interruption scenarios
- Testing recovery workflows during non-production periods
- Measuring exercise outcomes against ISO 22301 criteria
- Documenting lessons learned in audit-ready formats
- Updating plans based on exercise findings
- Scheduling exercises around product release timelines
- Integrating continuity drills into annual training cycles
- Validating vendor participation in live simulations
- Using metrics to demonstrate continuous improvement
- Reporting exercise results to executive leadership
- Aligning exercise frequency with product portfolio risk
Module 7. Integrating Continuity with Quality and Regulatory Systems
Embed ISO 22301 continuity practices into QMS, change control, and regulatory reporting workflows.
12 chapters in this module
- Linking continuity plans to deviation management systems
- Triggering continuity protocols from quality alerts
- Change control for continuity plan updates
- Integrating continuity documentation into eDMS
- Audit trail requirements for plan modifications
- Regulatory reporting obligations during disruptions
- Notifying health authorities of manufactured product delays
- Maintaining cGMP compliance during recovery
- Documenting continuity actions in batch records
- Aligning with ICH Q9 quality risk management principles
- Integrating with pharmacovigilance escalation paths
- Reporting continuity events in annual product reviews
Module 8. Leading Continuity Across Stakeholder Groups
Drive alignment across technical, regulatory, and commercial teams to build unified continuity capability.
12 chapters in this module
- Communicating continuity priorities to C-suite leaders
- Engaging commercial teams on supply reliability messaging
- Collaborating with procurement on dual-source validation
- Partnering with facilities on utility redundancy
- Working with IT on data recovery SLAs
- Aligning with clinical operations on trial supply
- Negotiating vendor recovery commitments
- Presenting continuity metrics to board-level committees
- Building cross-functional crisis response teams
- Developing joint escalation playbooks
- Creating shared ownership of recovery timelines
- Measuring stakeholder confidence in continuity plans
Module 9. Auditor and Regulator Readiness for Continuity Programs
Prepare for regulatory scrutiny of continuity programs with evidence that meets ISO 22301 and FDA/EMA expectations.
12 chapters in this module
- Organizing evidence for unannounced inspections
- Demonstrating plan execution during simulated audits
- Documenting decision rationale for recovery choices
- Providing auditor access to continuity test results
- Aligning with MHRA GMP inspection checklist items
- Responding to EMA questions on supply continuity
- Preparing for FDA Bioresearch Monitoring inspections
- Using ISO 22301 certification as compliance leverage
- Presenting recovery metrics in regulatory dossiers
- Handling document requests during business disruption
- Justifying investment in continuity to inspectors
- Maintaining audit readiness between review cycles
Module 10. Funding and Scaling Continuity Initiatives
Turn continuity from cost center to strategic investment with clear ROI and expansion pathways.
12 chapters in this module
- Building business cases for continuity improvements
- Quantifying cost of downtime in executive terms
- Securing capital for dual-source validation projects
- Aligning continuity spending with product lifecycle
- Using ISO 22301 certification to win new partners
- Positioning continuity as competitive differentiator
- Integrating continuity into corporate ESG reporting
- Measuring ROI of recovery investments
- Scaling successful pilots to global footprint
- Leveraging continuity for regulatory fast-track eligibility
- Creating reusable playbooks across product lines
- Building internal consultancy for continuity best practices
Module 11. Advanced Topics in Biopharma Operational Resilience
Address emerging threats and complexities in global biomanufacturing continuity.
12 chapters in this module
- Cyber resilience in automated bioprocessing systems
- Climate risk impact on facility operations
- Geopolitical risk in international supply chains
- Pandemic preparedness for essential personnel
- Workforce continuity during public health crises
- Resilience implications of AI-driven process control
- Energy transition risks in carbon-intensive processes
- Water scarcity impacts on biomanufacturing
- Resilience considerations in continuous manufacturing
- Security risks in outsourced production networks
- Contingency planning for gene therapy vectors
- Long-term storage failure recovery for cell therapies
Module 12. Sustaining Continuity Leadership Beyond Certification
Ensure long-term operational resilience through cultural integration, leadership succession, and continuous improvement.
12 chapters in this module
- Embedding continuity into leadership onboarding
- Mentoring next-gen COOs in resilience mindset
- Maintaining executive engagement post-certification
- Integrating continuity into performance metrics
- Rewarding proactive risk identification
- Updating plans as new products enter pipeline
- Adapting to regulatory change across markets
- Sharing best practices across industry consortia
- Contributing to ISO working groups
- Publishing case studies on successful recoveries
- Teaching continuity in industry forums
- Leaving a legacy of unbroken operational excellence
How this maps to your situation
- Current role as COO overseeing multi-process manufacturing
- Need to demonstrate regulatory and operational resilience
- Opportunity to expand budget and influence through proven continuity
- Expectation to lead strategic initiatives beyond cost control
Before vs. after
Before
Continuity efforts remain fragmented across teams, reactive to audits, and difficult to fund proactively.
After
Lead integrated, well-funded continuity programs that enhance regulatory standing and operational agility.
What's included with your purchase
- 12 modules with 12 chapters each (144 chapters)
- Downloadable templates and worked examples for every module
- Hand-built implementation playbook delivered alongside course access
- 30-day money-back guarantee
Delivery and format
- Course and learning environment access provisioned within 24 hours of purchase
- Hand-built implementation playbook delivered alongside course access
Format: Text-based modules and chapters in the Art of Service learning environment, plus downloadable templates and worked examples for every chapter, plus the hand-built implementation playbook delivered alongside course access.
Time investment: Approximately 6-8 hours per module, designed for completion over 6-8 weeks with real-world application.
If nothing changes
Without structured continuity leadership, organizations face prolonged downtime, regulatory scrutiny, partner attrition, and lost opportunity to shape resilience strategy.
How this compares to the alternatives
Unlike generic ISO 22301 courses, this program is tailored to biopharma manufacturing COOs, addressing cGMP environments, regulatory expectations, and complex supply chains with precision.
Frequently asked
How is the course structured?
12 modules, each containing 12 chapters (144 chapters total).
Is the content specific to biopharmaceutical manufacturing?
Yes, every module addresses real-world challenges in biologics production, regulatory compliance, and multi-site continuity.
Can I apply this to global operations?
Yes, the course covers harmonization across regions, regulatory bodies, and time zones with practical implementation tools.
$199 one-time. Approximately 6-8 hours per module, designed for completion over 6-8 weeks with real-world application..
Within 24 hours your account in the learning environment is provisioned and the tailored implementation playbook is delivered alongside it.
30-day money-back guarantee·
144 chapters·
Hand-built playbook included·
Account access within 24 hours